243 related articles for article (PubMed ID: 32873569)
1. Copy-Number Alteration Burden Differentially Impacts Immune Profiles and Molecular Features of Hepatocellular Carcinoma.
Bassaganyas L; Pinyol R; Esteban-Fabró R; Torrens L; Torrecilla S; Willoughby CE; Franch-Expósito S; Vila-Casadesús M; Salaverria I; Montal R; Mazzaferro V; Camps J; Sia D; Llovet JM
Clin Cancer Res; 2020 Dec; 26(23):6350-6361. PubMed ID: 32873569
[TBL] [Abstract][Full Text] [Related]
2. Genomic structures of dysplastic nodule and concurrent hepatocellular carcinoma.
Lee M; Kim K; Kim SY; Jung SH; Yoon J; Kim MS; Park HC; Jung ES; Chung YJ; Lee SH
Hum Pathol; 2018 Nov; 81():37-46. PubMed ID: 29949741
[TBL] [Abstract][Full Text] [Related]
3. CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications.
Franch-Expósito S; Bassaganyas L; Vila-Casadesús M; Hernández-Illán E; Esteban-Fabró R; Díaz-Gay M; Lozano JJ; Castells A; Llovet JM; Castellví-Bel S; Camps J
Elife; 2020 Jan; 9():. PubMed ID: 31939734
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of genomic and immunological profiles in Chinese and Western hepatocellular carcinoma populations.
Li W; Wu H; Xu X; Zhang Y
Aging (Albany NY); 2021 Apr; 13(8):11564-11594. PubMed ID: 33867349
[TBL] [Abstract][Full Text] [Related]
5. Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features.
Sia D; Jiao Y; Martinez-Quetglas I; Kuchuk O; Villacorta-Martin C; Castro de Moura M; Putra J; Camprecios G; Bassaganyas L; Akers N; Losic B; Waxman S; Thung SN; Mazzaferro V; Esteller M; Friedman SL; Schwartz M; Villanueva A; Llovet JM
Gastroenterology; 2017 Sep; 153(3):812-826. PubMed ID: 28624577
[TBL] [Abstract][Full Text] [Related]
6. Characterization of copy number alterations in a mouse model of fibrosis-associated hepatocellular carcinoma reveals concordance with human disease.
Chappell G; Silva GO; Uehara T; Pogribny IP; Rusyn I
Cancer Med; 2016 Mar; 5(3):574-85. PubMed ID: 26778414
[TBL] [Abstract][Full Text] [Related]
7. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
Moeini A; Sia D; Zhang Z; Camprecios G; Stueck A; Dong H; Montal R; Torrens L; Martinez-Quetglas I; Fiel MI; Hao K; Villanueva A; Thung SN; Schwartz ME; Llovet JM
J Hepatol; 2017 May; 66(5):952-961. PubMed ID: 28126467
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive molecular and immunological characterization of hepatocellular carcinoma.
Shimada S; Mogushi K; Akiyama Y; Furuyama T; Watanabe S; Ogura T; Ogawa K; Ono H; Mitsunori Y; Ban D; Kudo A; Arii S; Tanabe M; Wands JR; Tanaka S
EBioMedicine; 2019 Feb; 40():457-470. PubMed ID: 30598371
[TBL] [Abstract][Full Text] [Related]
9. Trunk mutational events present minimal intra- and inter-tumoral heterogeneity in hepatocellular carcinoma.
Torrecilla S; Sia D; Harrington AN; Zhang Z; Cabellos L; Cornella H; Moeini A; Camprecios G; Leow WQ; Fiel MI; Hao K; Bassaganyas L; Mahajan M; Thung SN; Villanueva A; Florman S; Schwartz ME; Llovet JM
J Hepatol; 2017 Dec; 67(6):1222-1231. PubMed ID: 28843658
[TBL] [Abstract][Full Text] [Related]
10. Target genes discovery through copy number alteration analysis in human hepatocellular carcinoma.
Gu DL; Chen YH; Shih JH; Lin CH; Jou YS; Chen CF
World J Gastroenterol; 2013 Dec; 19(47):8873-9. PubMed ID: 24379610
[TBL] [Abstract][Full Text] [Related]
11. Multiregional whole-genome sequencing of hepatocellular carcinoma with nodule-in-nodule appearance reveals stepwise cancer evolution.
Takeda H; Takai A; Kumagai K; Iguchi E; Arasawa S; Eso Y; Shimizu T; Ueda Y; Taura K; Uemoto S; Kita R; Haga H; Marusawa H; Fujimoto A; Seno H
J Pathol; 2020 Dec; 252(4):398-410. PubMed ID: 32815153
[TBL] [Abstract][Full Text] [Related]
12. Sarcomatoid hepatocellular carcinoma is distinct from ordinary hepatocellular carcinoma: Clinicopathologic, transcriptomic and immunologic analyses.
Morisue R; Kojima M; Suzuki T; Nakatsura T; Ojima H; Watanabe R; Sugimoto M; Kobayashi S; Takahashi S; Konishi M; Ishii G; Gotohda N; Fujiwara T; Ochiai A
Int J Cancer; 2021 Aug; 149(3):546-560. PubMed ID: 33662146
[TBL] [Abstract][Full Text] [Related]
13. Single-Cell DNA Sequencing Reveals Punctuated and Gradual Clonal Evolution in Hepatocellular Carcinoma.
Guo L; Yi X; Chen L; Zhang T; Guo H; Chen Z; Cheng J; Cao Q; Liu H; Hou C; Qi L; Zhu Z; Liu Y; Kong R; Zhang C; Zhou X; Zhang Z; Song T; Xue R; Zhang N
Gastroenterology; 2022 Jan; 162(1):238-252. PubMed ID: 34481846
[TBL] [Abstract][Full Text] [Related]
14. Genomic landscape of lymphoepithelioma-like hepatocellular carcinoma.
Chan AW; Zhang Z; Chong CC; Tin EK; Chow C; Wong N
J Pathol; 2019 Oct; 249(2):166-172. PubMed ID: 31168847
[TBL] [Abstract][Full Text] [Related]
15. Loss at 16q22.1 identified as a risk factor for intrahepatic recurrence in hepatocellular carcinoma and screening of differentially expressed genes.
Chen L; Zhu ZZ; Liu SF; Wan X; Wen BJ; Jiang H; Zhu J; Cong WM
Neoplasma; 2016; 63(1):114-20. PubMed ID: 26639241
[TBL] [Abstract][Full Text] [Related]
16. Integrated exome sequencing and microarray analyses detected genetic defects and underlying pathways of hepatocellular carcinoma.
Chong ML; Knight J; Peng G; Ji W; Chai H; Lu Y; Wu S; Li P; Hu Q
Cancer Genet; 2023 Aug; 276-277():30-35. PubMed ID: 37418972
[TBL] [Abstract][Full Text] [Related]
17. Integrative molecular analysis of metastatic hepatocellular carcinoma.
Wang D; Zhu Y; Tang J; Lian Q; Luo G; Wen W; Zhang MQ; Wang H; Chen L; Gu J
BMC Med Genomics; 2019 Nov; 12(1):164. PubMed ID: 31722693
[TBL] [Abstract][Full Text] [Related]
18. Epigenomic profiling of DNA methylation for hepatocellular carcinoma diagnosis and prognosis prediction.
Zhang C; Ge S; Wang J; Jing X; Li H; Mei S; Zhang J; Liang K; Xu H; Zhang X; Zhang C
J Gastroenterol Hepatol; 2019 Oct; 34(10):1869-1877. PubMed ID: 31038805
[TBL] [Abstract][Full Text] [Related]
19. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
[TBL] [Abstract][Full Text] [Related]
20. Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
Ding X; He M; Chan AWH; Song QX; Sze SC; Chen H; Man MKH; Man K; Chan SL; Lai PBS; Wang X; Wong N
Gastroenterology; 2019 Dec; 157(6):1630-1645.e6. PubMed ID: 31560893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
